James Spencer

James Spencer is an experienced oncology account specialist currently working at Regeneron since January 2023. Prior to this role, James served as an oncology therapeutic specialist at Incyte from September 2020 to December 2022 and as a clinical oncology specialist at Genentech from August 2011 to September 2020, focusing on lung and urothelial cancers as well as melanoma. James also held a clinical oncology specialist position at Genentech from April 2010 to January 2011, promoting Herceptin for breast and gastric cancer in Oregon and Alaska. Previous experience includes serving as a health systems manager at Amgen and regional account manager at GlaxoSmithKline, with responsibilities spanning a wide range of medical institutions. James holds a Bachelor of Science in Biology from Portland State University.